Home

Welcome to SWEBAGS

The Swedish Basal Ganglia Society, SWEBAGS, is an non-profit scientific organization providing a platform for discussions and education opportunities in the area of basal ganglia research.

We aim to increase the visibility of mainly basic and pre-clinical research, and foster multidisciplinary collaborations across biological scales and methodological approaches. All professionals, students and organisations interested in basal ganglia research are welcome to become members.

Together we will leverage the strengths of basal ganglia research in Sweden, join us in our efforts and participate in our activities!

– Jeanette Hellgren Kotaleski, Professor, KTH Royal Institute of technology, Chair SWEBAGS
– Angela Cenci Nilsson, Professor, Lund University, Vice Chair SWEBAGS

Latest News:

SWEBAGS mourns the loss of our esteemed member Prof Ernest

We are deeply saddened by the news of Professor Ernest Arenas’ passing. While we are immensely grateful for his significant contributions to basal ganglia research, our thoughts are with his family, friends, and colleagues during this difficult time. Karolinska Institutet has shared an obituary, which can be read here: Karolinska Institutet obituary.

Continue Reading

Extended Abstract Submission Deadline

We understand that many of you have tried to submit an abstract and register for the conference via the SWEBAGS website without succeeding. We sincerely apologize for the inconvenience caused by the downtime of our website. We are pleased to inform you that the issue has been fully resolved, and our site is now back…

Continue Reading

New Publication: Concerning neuromodulation as treatment of neurological and neuropsychiatric disorder: Insights gained from selective targeting of the subthalamic nucleus, para-subthalamic nucleus and zona incerta in rodents

Authors: Alessia Ricci, Eleonora Rubino, Gian Pietro Serra, Åsa Wallén-Mackenzie Abstract: Neuromodulation such as deep brain stimulation (DBS) is advancing as a clinical intervention in several neurological and neuropsychiatric disorders, including Parkinson´s disease, dystonia, tremor, and obsessive-compulsive disorder (OCD) for which DBS is already applied to alleviate severely afflicted individuals of symptoms. Tourette syndrome and…

Continue Reading

More news …